Senior Clinical Research Professional with nearly 20 years of experience in clinical research and public health. I began my career at the World Health Organization’s National Influenza Center under the Russian Ministry of Health, supporting national infectious disease surveillance and response.
Since 2018, I’ve expanded my expertise in the U.S. as a Clinical Research Coordinator and Start-Up Manager, overseeing a wide range of industry-sponsored trials across therapeutic areas including CNS, GI, OB/GYN, vaccines, hematology, and rheumatology. I’ve contributed to high-impact COVID-19 vaccine trials for Pfizer, Moderna, Johnson & Johnson, and Novavax—three of which led to FDA approvals.
Detail-oriented and dependable, I bring strong communication and interpersonal skills, with a commitment to patient care and safety. Skilled at managing high-pressure environments, I consistently deliver high-quality, reliable data while ensuring compliance with GCP and ICH guidelines. Passionate about advancing medical knowledge, I aim to support innovation and improve patient outcomes through excellence in clinical trial execution and oversight.
• Coordinated, organized, and maintained all study documentation including source documentation, case report forms (maintaining accurate records of Adverse Events and expedited reports of Serious Adverse Events), study and regulatory binders, and patient binders.
• Oversaw adherence to study protocols involving influenza vaccines and novel influenza treatments, including clinical patient evaluations, treatment administration, and collection, processing, and shipping of biological specimens.
• Prepared and submitted all necessary documentation to the Institutional Review Board (IRB), including initial submissions, continuing reviews, amendments, and adverse event reporting.
• Prepared for and actively participated in audits conducted by sponsors and oversight bodies such as CHOP’s Regulatory and Compliance Office.
• Managed the day-to-day operational aspects of multiple concurrent clinical trials to ensure timelines and regulatory requirements were met.
• Contributed to vaccine production research, including studies on mRNA-based vaccines, focusing on immunogenicity, stability, and delivery mechanisms.
• Participated in research on herd immunity thresholds and population-based vaccine coverage models to support public health strategies.
• Conducted statistical analysis for publications assessing the clinical efficacy of vaccines, including data management, outcome interpretation, and manuscript preparation for peer-reviewed journals.
• Studied the main evolutionary patterns of the development of intellectual activity in primates of different levels of phylogeny, from representatives of lower monkeys (marmoset) to the most highly organized primates (chimpanzees)
• Prepared fact sheets, tables and graphs to summarize research results
• Interpreted and analyzed research data to draw conclusions on outcomes
• Basic animal care
Collaborative Institutional Training Initiative (CITI): CITI Good Clinical Practice (US FDA Focus) GCP for Clinical Trials with Investigational Drugs and Medical Devices ID: 67200775 Exp. 26-MAR-2028
Collaborative Institutional Training Initiative (CITI): Shipping and Transport of Regulated Biological Materials ID: 63392879 Exp. 14-AUG-2025
OSHA (Occupational Safety and Health Administration) Training ID: 26-707454367